HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gianpietro Dotti Selected Research

Doxorubicin (Adriamycin)

12/2020Cryo-shocked cancer cells for targeted drug delivery and vaccination.
1/2018T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gianpietro Dotti Research Topics

Disease

140Neoplasms (Cancer)
04/2024 - 07/2002
15Neuroblastoma
01/2024 - 11/2008
14Hematologic Neoplasms (Hematological Malignancy)
12/2023 - 09/2008
11Lymphoma (Lymphomas)
04/2024 - 10/2002
11Leukemia
04/2024 - 02/2003
10Melanoma (Melanoma, Malignant)
11/2023 - 09/2008
10Graft vs Host Disease (Graft-Versus-Host Disease)
04/2016 - 11/2003
9Hodgkin Disease (Hodgkin's Disease)
03/2024 - 10/2007
9Glioblastoma (Glioblastoma Multiforme)
11/2023 - 01/2016
7B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2021 - 04/2003
5Cytokine Release Syndrome
04/2024 - 06/2015
5Breast Neoplasms (Breast Cancer)
04/2023 - 06/2007
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 11/2013
4Sarcoma (Soft Tissue Sarcoma)
04/2024 - 05/2015
4Brain Neoplasms (Brain Tumor)
11/2023 - 12/2011
4Multiple Myeloma
03/2019 - 01/2002
4Infections
06/2015 - 10/2002
3Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2024 - 12/2006
3Lung Neoplasms (Lung Cancer)
01/2022 - 01/2018
3Neoplasm Metastasis (Metastasis)
01/2021 - 01/2018
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 11/2014
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2019 - 01/2019
2Bites and Stings (Sting)
01/2023 - 01/2021
2Hyperthermia
06/2019 - 06/2015
2Glioma (Gliomas)
01/2017 - 02/2016
2Virus Diseases (Viral Diseases)
10/2013 - 08/2009
2Persistent Infection
12/2011 - 07/2011
2B-Cell Lymphoma (Lymphoma, B Cell)
05/2011 - 12/2006
2Testicular Neoplasms (Testicular Cancer)
03/2011 - 09/2008
1Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2024
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2024

Drug/Important Bio-Agent (IBA)

94Chimeric Antigen ReceptorsIBA
04/2024 - 11/2005
48AntigensIBA
02/2023 - 07/2002
14CytokinesIBA
03/2024 - 10/2007
13Interleukin-15 (Interleukin 15)IBA
04/2024 - 10/2007
10Neoplasm Antigens (Tumor Antigens)IBA
12/2023 - 04/2003
8Interleukin-2 (IL2)IBA
06/2014 - 10/2005
7Monoclonal AntibodiesIBA
01/2020 - 03/2005
6Proteins (Proteins, Gene)FDA Link
04/2023 - 04/2003
6VaccinesIBA
01/2019 - 04/2003
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2024 - 06/2015
5Immune Checkpoint InhibitorsIBA
11/2023 - 01/2018
5CD40 Ligand (CD40L)IBA
10/2011 - 07/2002
4fludarabineIBA
04/2024 - 06/2015
4Caspase 9IBA
04/2024 - 11/2014
4chondroitin sulfate proteoglycan 4IBA
01/2021 - 01/2015
3HydrogelsIBA
03/2024 - 10/2020
3Interleukin-12 (IL 12)IBA
01/2024 - 01/2018
3Chemokine CCL5IBA
11/2023 - 09/2014
3Ki-1 AntigenIBA
01/2022 - 06/2009
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 01/2015
3Immunoglobulins (Immunoglobulin)IBA
11/2021 - 10/2005
3B7-H1 AntigenIBA
01/2021 - 01/2018
3GD2 gangliosideIBA
10/2020 - 09/2009
3ErbB Receptors (EGF Receptor)IBA
01/2020 - 12/2011
3EpitopesIBA
01/2019 - 04/2012
3Therapeutic UsesIBA
01/2018 - 08/2010
3ChemokinesIBA
01/2018 - 06/2009
3AP 1903 reagentIBA
04/2016 - 11/2011
3CD19-specific chimeric antigen receptorIBA
01/2016 - 10/2013
3Interleukin-7 (Interleukin 7)IBA
06/2014 - 05/2009
2Disulfiram (Antabuse)FDA Link
02/2023 - 01/2023
2CopperIBA
02/2023 - 01/2023
2Messenger RNA (mRNA)IBA
01/2022 - 05/2015
2InterferonsIBA
01/2022 - 12/2021
2FibrinIBA
10/2021 - 01/2019
2vadimezanIBA
01/2021 - 01/2021
2Cancer VaccinesIBA
12/2020 - 01/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2020 - 01/2018
2InterleukinsIBA
10/2020 - 01/2013
2Panitumumab (Vectibix)FDA Link
01/2020 - 01/2020
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 01/2018
2Interferon-gamma (Interferon, gamma)IBA
01/2020 - 11/2005
2Cetuximab (Erbitux)FDA Link
01/2020 - 01/2020
2Chondroitin Sulfates (Chondroitin Sulfate)IBA
06/2019 - 02/2014
2AntibodiesIBA
01/2019 - 10/2014
2Transforming Growth Factors (Transforming Growth Factor)IBA
10/2018 - 06/2008
2CD19 AntigensIBA
01/2017 - 05/2011
2human ERBB2 proteinIBA
05/2015 - 06/2007
2AutoantigensIBA
01/2015 - 07/2002
2Antiviral Agents (Antivirals)IBA
10/2013 - 04/2010
2Viral AntigensIBA
10/2013 - 12/2011
2LigandsIBA
06/2009 - 03/2005
1Biocompatible Materials (Biomaterials)IBA
04/2024
1Interferon Type IIBA
04/2024
1MesothelinIBA
03/2024
1Anaplastic Lymphoma KinaseIBA
12/2023
1Conditioned Culture MediaIBA
11/2023

Therapy/Procedure

55Therapeutics
04/2024 - 03/2005
52Immunotherapy
01/2024 - 07/2002
7Drug Therapy (Chemotherapy)
01/2023 - 10/2002
6Stem Cell Transplantation
03/2024 - 08/2007
6Transplantation
03/2024 - 11/2003
4Cell- and Tissue-Based Therapy (Cell Therapy)
11/2023 - 12/2021
4Hematopoietic Stem Cell Transplantation
11/2015 - 11/2003
3Intravenous Administration
11/2023 - 01/2021
2Intravenous Infusions
01/2022 - 07/2009
2Radiotherapy
01/2021 - 10/2014
2Injections
10/2020 - 10/2014
1Salvage Therapy
03/2024